Silencing of FOS-like antigen 1 represses restenosis via the ERK/AP-1 pathway in type 2 diabetic mice

Restenosis is a major limiting factor for a successful outcome in type 2 diabetes (T2D) patients undergoing percutaneous coronary intervention (PCI). The aim of this study is to explore the role and regulatory mechanism of FOS-like antigen 1 (FOSL1) in restenosis in T2D. A T2D with restenosis mouse...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chaoxi, Wang, Fujun, Ma, Hongfang, Xing, Na, Hou, Lin, Du, Yaping, Ding, Haixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669130/
https://www.ncbi.nlm.nih.gov/pubmed/34881661
http://dx.doi.org/10.1177/14791641211058855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669130/
https://www.ncbi.nlm.nih.gov/pubmed/34881661
http://dx.doi.org/10.1177/14791641211058855

Ejemplares similares